Baseline characteristics of randomised patients
| Characteristic | Mesalazine (N=68) | Placebo (N=68) | ||
|---|---|---|---|---|
| Age at enrolment: mean (SD) | 42.6 (15.2) | 47.1 (13.5) | ||
| Gender N (%) | Male 26 (38.2%) | Male 28 (41.2%) | ||
| Female 42 (61.8%) | Female 40 (58.8%) | |||
| Daily average stool frequency Mean (SD) | 3.6 (1.6) | 3.6 (1.8) | ||
| Daily mean abdominal pain score Mean (SD) | 4.1 (2.2) | 3.6 (2.0) | ||
| Number of days with urgency Median (IQR) | 13 (10,14) | 12 (9,14) | ||
| Stool consistency Mean (SD) | 5.4 (0.7) | 5.6 (1.0) | ||
| Hospital anxiety and depression score | ||||
| Anxiety score Mean (SD) | 9.1 (4.5) | 8.6 (4.3) | ||
| Depression score Mean (SD) | 5.6 (4.2) | 5.0 (3.3) | ||
| PHQ12-SS score Mean (SD) | 7.8 (4.5) | 8.2 (5.2) | ||
PHQ12-SS, Patient Health Questionnaire-12 Somatic Symptom Scale.